A new clinical trial has shown nine patients with advanced kidney cancer mounted an immune response and remained cancer-free for three years after receiving an experimental vaccine tailored to their unique tumor mutations. The study, published in Nature, demonstrates the potential of personalized vaccines to treat certain types of cancer. While larger trials are needed to confirm this approach, experts believe that these vaccines have a promising future, with further research necessary to compare them to standard treatments.
Source: https://www.statnews.com/2025/02/05/personalized-cancer-vaccine-kidney-dana-farber-yale